<DOC>
	<DOCNO>NCT00283621</DOCNO>
	<brief_summary>To determine percentage patient number cycle pack red blood cell transfusion administer due anemia antibiotic administer due neutropenic fever .</brief_summary>
	<brief_title>Aranesp Neulasta Patients With Sarcoma Receiving Adriamycin Ifosfamide</brief_title>
	<detailed_description>The use hematopoietic growth factor show reduce neutropenic complication red cell transfusion requirement associate chemotherapy . This trial study combination pegfilgrastim darbepoetin alfa administer per cycle chemotherapy . Prior experience growth factor set provide historical data comparison safety activity newer longer acting growth factor reduce incidence febrile neutropenia require antibiotic anemia require transfusion . The dose per cycle would simplify patient management would improve patient convenience compliance .</detailed_description>
	<mesh_term>Sarcoma</mesh_term>
	<mesh_term>Doxorubicin</mesh_term>
	<mesh_term>Liposomal doxorubicin</mesh_term>
	<mesh_term>Isophosphamide mustard</mesh_term>
	<mesh_term>Ifosfamide</mesh_term>
	<mesh_term>Darbepoetin alfa</mesh_term>
	<criteria>Patients sarcoma locally advance , high risk relapse metastatic treatment AI indicate Must 1865 year age Women childbearing potential use effective contraceptive measure Adequate hematologic , renal , hepatic function Karnofsky performance status equal 80 Pregnant lactate woman . Patients comorbid condition render patient high risk treatment complication Patients metastatic disease CNS Patients significant cardiac abnormality History seizure disorder past 5 year Patient receive packed red blood cell transfusion within 2 week study entry Prior surgery radiation therapy within 2 week study entry History prior chemotherapy sarcoma Iron deficiency Hypersensitivity E.coli derive product</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>Aranesp</keyword>
	<keyword>Darbepoetin Alfa</keyword>
	<keyword>Pegfilgrastim</keyword>
	<keyword>Neulasta</keyword>
	<keyword>Sarcoma</keyword>
	<keyword>Adriamycin</keyword>
	<keyword>Doxorubicin Hydrocholoride</keyword>
	<keyword>Adriamycin PFS</keyword>
	<keyword>Adriamycin RDF</keyword>
	<keyword>Ifosfamide</keyword>
</DOC>